title: [Acute localized pneumopathies. Should macrolides always be prescribed initially?].
authors.forename: B
authors.initials: B
authors.lastname: Dautzenberg
authors.forename: C
authors.initials: C
authors.lastname: Gallinari
authors.forename: O
authors.initials: O
authors.lastname: Axler
authors.forename: A
authors.initials: A
authors.lastname: Moreau
authors.forename: J
authors.initials: J
authors.lastname: Nguyen
authors.forename: V
authors.initials: V
authors.lastname: Jarlier
authors.forename: M H
authors.initials: MH
authors.lastname: Fievet
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D004917:Erythromycin
vernacular_title: Pneumopathies aiguës localisées. Faut-il toujours prescrire un macrolide en première intention?